Why Lupus Causes Low Serum Iron
Lupus causes low serum iron primarily through inflammation-driven hepcidin elevation, which blocks iron release from body stores (functional iron deficiency), combined with anemia of chronic disease and true iron deficiency from chronic blood loss. 1, 2
Primary Mechanism: Inflammation-Induced Hepcidin Elevation
The dominant mechanism is functional iron deficiency caused by chronic inflammation in SLE:
- IL-6 and other inflammatory cytokines directly induce hepcidin transcription via the STAT-3 pathway in hepatocytes 1
- Elevated hepcidin degrades ferroportin, the iron exporter on macrophages and enterocytes, trapping iron in reticuloendothelial stores and preventing dietary absorption 1
- This creates a paradoxical state where total body iron stores may be adequate (elevated ferritin), but serum iron remains low because iron cannot be mobilized from storage sites 1
- Ferritin levels are falsely elevated in SLE as an acute phase reactant, masking true iron deficiency 2, 3
Secondary Mechanisms Contributing to Low Iron
Anemia of Chronic Disease (ACD)
- ACD is present in 23-68% of SLE patients with anemia, representing the most common etiology alongside autoimmune hemolytic anemia 4, 3
- The inflammatory state directly suppresses erythropoiesis and shortens red cell survival 2
- Hemoglobin levels negatively correlate with ESR, ferritin, and SLEDAI scores, confirming the inflammation-anemia relationship 4
True Iron Deficiency
- Absolute iron deficiency coexists with ACD in up to 58% of SLE patients when assessed by soluble transferrin receptor (sTfR) rather than ferritin alone 3
- Chronic blood loss occurs from multiple sources: gastrointestinal bleeding (NSAIDs, vasculitis), menorrhagia, and frequent phlebotomy 5, 4
- Iron deficiency becomes the predominant cause of new-onset anemia during follow-up, particularly in patients with renal involvement 4
Altered Iron Handling and Cellular Dysfunction
- SLE patients exhibit dysregulated cellular iron metabolism with iron accumulation in immune cells and renal tubules despite low serum iron 6, 7
- This creates intracellular iron depletion in effector immune cells while paradoxically causing iron-mediated oxidative damage in tissues 6
- Accelerated eryptosis (red cell death) contributes to hemolytic anemia and further iron dysregulation 8
Clinical Implications and Diagnostic Pitfalls
Key Diagnostic Considerations
- Serum ferritin is unreliable in SLE due to acute phase elevation; ferritin >150 μg/L does not exclude iron deficiency in inflammatory states 9, 2
- Soluble transferrin receptor (sTfR) is superior to ferritin for detecting true iron deficiency in SLE, revealing coexisting iron deficiency in the majority of cases initially classified as pure ACD 3
- Transferrin saturation (TSAT) <20% with ferritin 100-299 μg/L indicates functional iron deficiency requiring treatment 10
Association with Disease Activity
- Anemia severity correlates with disease activity markers: patients with anemia have significantly higher SLEDAI scores, positive ds-DNA antibodies, and elevated ESR 4
- Low C3 complement and thrombocytopenia are associated with both renal disease and hematologic complications, including anemia 8
- Rapid recurrence of iron deficiency should prompt evaluation for subclinical disease flare 11
Treatment Considerations
- Intravenous iron is preferred over oral iron in inflammatory states, as oral absorption is impaired by hepcidin elevation 11, 10
- Oral iron may exacerbate inflammation and alter gut microbiota in chronic inflammatory conditions 11
- Target ferritin levels of 100-400 μg/L post-treatment to prevent rapid recurrence 11
- Monitor iron status every 3 months after correction, avoiding early reassessment within 4 weeks of IV iron (ferritin falsely elevated) 10